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Introduction
Helicobacter pylori is a Gram-negative microaerophilic
bacterium that infects human gastric mucosa and is
recognised as a major cause of chronic active gastritis, peptic
ulcer disease, gastric adenocarcinoma and gastric mucosa-
associated lymphoid tissue lymphoma.1,2 It also has a
relationships with gastro-oesophageal reflux disease and
adenocarcinoma of the gastric cardia.3 It is a class I
carcinogen that colonises the human stomach of more than
50% of the world’s population. However, only a small subset
of infected people experience H. pylori-associated illnesses. 
Although the pathogenesis of H. pylori infection is not well
understood, there are several virulence factors that may
contribute to mucosal damage. The cagA gene is
conventionally used as a marker of pathogenic strains.
However, the literature suggests that the cagA gene alone is
not a suitable marker of H. pylori virulence. A strong
predictor of severe disease outcome is infection with a
bacterial strain harbouring the cag pathogenicity island 
(cag-PAI), a 40 kb segment of DNA.4
H. pylori cag-PAI is horizontally acquired and follows free
recombinations within the species. The chromosomal
integrity of this island, or the lack thereof, is thought to play
an important role in the progress of the gastroduodenal
pathology caused by H. pylori. These genes encode a type IV
secretion system that forms a syringe-like structure to
translocate the immunodominant cagA protein into the
gastric epithelial cells.5 cag-PAI has also been implicated in
the induction of interleukin-8 (IL-8) in cultured gastric cells.6
At least 17 out of 27 genes were found to be essential for
translocation of cagA into host cells (syringe-like function),
and 14 were required to fully induce transcription of IL-8.6
The cag-PAI and vacuolating toxin A (vacA) gene are located
far apart on the chromosome, but there is a statistical linkage
between presence of the cag-PAI and the s1 genotype of
vacA.7 Strains with this genotype are called type I strains and
are generally more virulent than type II strains that lack the
cag-PAI and harbour the less virulent vacA s2 genotype.8
The aim of this study is to determine the association of
cagA with intact cag-PAI to evaluate inflammatory changes
associated with intact cag-PAI and determine any association
between cag-PAI and the vacA allele s1. The completeness of
cag-PAI is determined using specific flanking polymerase
chain reaction (PCR) primers from five loci in the H. pylori
cag-PAI comprising cagA, cagA promoter region (cagAP),
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ABSTRACT
Clinical diseases that follow Helicobacter pylori infection are
associated with expression of the cagA gene, a part of
cytotoxin-associated gene pathogenicity island (cag-PAI).
This study aims to determined whether or not the presence
of cagA is associated with the presence of complete cag-PAI
and to evaluate inflammatory changes associated with the
five loci in the cag-PAI of H. pylori comprising cagA, cagA
promoter region (cagAP), cagE, cagT and the left end of the
cagA gene (LEC). H. pylori isolates were obtained from
patients with dyspeptic symptoms. Clinical strains of 
H. pylori were screened by the polymerase chain reaction
(PCR) for respective genes of the cag-PAI. Of 115 H. pylori
isolates, 31 (28%) were positive for the five cag-PAI loci. 
H. pylori isolates with intact cag-PAI were associated 
with gastric carcinoma (GC; n=9[60%]) and gastric ulcer 
(GU; n=5[45%]) compared to non-ulcer dyspepsia 
(NUD; n=14[18%]) (P=0.001 and P=0.049, respectively). 
In patients with intact cag-PAI, acute on chronic
inflammation was present in 25 (81%) and was more
common than chronic inflammation (P=0.013). The cagE
and cagAP had deletions in 25 (37%) and 23 (35%) cases,
respectively. The cagAP region was significantly associated
with GC (n=12[80%], P<0.001) and GU (n=9[82%],
P=0.001) compared to NUD (n=24[30%] and with
significant acute on chronic inflammation (n=40[80%],
P=0.007). The distribution of vacAs1a with intact cag-PAI in
GC was 9(60%) and in NUD was 10(13%) (P<0.001). The
presence of the cagA gene does not signify presence of an
intact cag-PAI. Most of the H. pylori isolates studied had
partial cag-PAI with missing cagE and cagA promoter
regions.
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cagE, cagT and the left end of the cag-PAI (LEC) in clinical
isolates of H. pylori. The absence of cag-PAI is detected by the
PCR for the cag empty site flanking the left and right ends of
the cag-PAI indicating that they truly lacked the cagA gene.9
Materials and methods
Patients and H. pylori strains
A total of 115 H. pylori isolates were obtained from patients
undergoing gastroscopy and gastric biopsy for dyspeptic
symptoms attending the endoscopy suite of the
gastroenterology department at the Aga Khan University
from July 2005 to December 2007 (Table 1). Mean age was
40±14 years (range: 18–78 years). Informed consent was
obtained for oesophagogastroduodenoscopy (EGD) and
biopsy from the antrum and body of the stomach. The study
was approved by the institution’s ethics review committee.
Sterilised biopsy forceps were used to obtain gastric
biopsy specimens from an area of inflammation for rapid
urease test, histopathology, cag-PAI-associated virulence
genes, cagA empty site and vacA PCR. 
After primary isolation and identification of the gastric
organisms as H. pylori, the strains were frozen at –70˚C until
their use in the study. Subsequently, bacteria were cultured
on Columbia blood agar (Oxoid) plates containing 7% sheep
blood for 3–5 days at 37˚C under microaerobic conditions
using Campygen strips in anaerobic jars (Oxoid).
Several small, rounded colonies were picked from
different parts of the culture plate and subcultured twice to
obtain a pure culture. Gram’s stain, urease and catalase tests
were used to confirm identification and to exclude the
possibility of contamination.
H. pylori cells were harvested from plates by suspension in
2-mL sterile phosphate-buffered saline (PBS) and were
pelleted by centrifugation at 3000 xg for 20 min. The clinical
symptoms at the time of presentation, diagnosis, drug
treatment dosage and duration were noted, together with
endoscopy findings. 
Rapid urease test 
Pronto Dry, a commercial rapid urease test (Medical
Instrument Corp., France), results were read in 30 min after
sampling, in accordance with the manufacturer ’s
instructions. Colour change from yellow to pink was
indicative of a positive reaction.10
Histopathology
Gastric antral biopsy specimens stained with haematoxylin
and eosin (H&E) were examined by a pathologist unaware
of the patient’s clinical diagnosis. In doubtful cases, Giemsa
staining was performed to ascertain the presence of H. pylori.
Degree of gastritis on H&E stain was scored in accordance
with the Sydney system11 for the level of inflammation and
neutrophil infiltration (0=none, 1=mild, 2=moderate,
3=severe).
Extraction of genomic DNA
DNA was extracted from confluent cultures with fewer than
three in vitro passages.12 The bacterial cells from a chocolate
agar plate were washed (x2) with PBS and centrifuged at
3000 xg for 20 min. H. pylori DNA was extracted by a
modified phenol/chloroform method.13 Briefly, a bacterial
pellet was resuspended in Tris-HCl buffer containing
ethylenediaminetetraacetate (TE, pH 8.0) and lysozyme (30
mg/mL) and was incubated at 37˚C for 30 min. The
suspension was treated with sodium dodecyl sulphate (SDS,
10%), proteinase K (2.5 mg/mL) and RNase A (40 mg/mL).
DNA was extracted with phenol/chloroform/isoamyl
alcohol, precipitated by sodium acetate and ice-cold absolute
alcohol, and washed with ice-cold alcohol (70%). The DNA
pellet was finally resuspended in TE buffer. DNA content
and purity were determined by measuring absorbance at 
260 nm and 280 nm using a spectrophotometer (Beckman
DU-600, USA).
cag-PAI PCR analysis 
The PCR analyses were carried out with oligonucleotide
pairs (Table 2A), as described previously,14 to amplify five
different loci spread over the cag I and cag II regions. cagA,
the cagA promoter region and cagE represented cagI, while
the left end of cag (LEC) and cagT were selected to represent
cagII. 
Pairs of oligonucleotide primers were used to detect the
presence of the cag-PAI genes (cagA, the cagAP region, cagE,
cagT and the LEC, containing both inside and outside genes
of cag-PAI). These primer pairs were designed on the basis of
published sequences.4,9,15 To test for the absence of the 
cag-PAI, PCR for the cag empty-site was used with primers
that flanked the left and right ends of the cag-PAI.9
H. pylori strains ATCC 43526 and ATCC 43504, which have
been determined to have the entire cag-PAI, were used as
positive controls, and ATCC 51932 was used as a negative
control as it lacks cagA. Amplification specificity for the
different loci was assessed by testing H. pylori strains 
ATCC 43526, ATCC 43504 and ATCC 51932 with each
experiment. Amplification by PCR was performed in 25-µL
volumes containing 10 mmol/L Tris-HCl (pH 8.3), 50 mmol/L
KCl, 1.5–2.5 mmol/L MgCl2, 200 µmol/L deoxynucleoside
triphosphates, 2 units Thermus aquaticus (Taq) DNA
polymerase (Promega) and 25 ρmol both forward and
reverse primers (synthesised using an MWG automatic
synthesiser). The total volume was made up with double-
distilled water (DDW). 
Amplification was performed in a Perkin Elmer 9700
thermal cycler (Applied Biosystems). The cycles comprised
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Gender Male: Female 77:38
Age Range 18–78 years
Mean age±SD 40±14 years
Symptoms Abdominal pain 92 (82%)
Vomiting 13 (10%)
Weight loss 10 (8%)
Diagnosis Non-ulcer dyspepsia 79 (69%)
Gastric ulcer 11 (9%)
Gastric carcinoma 15 (13%)
Duodenal ulcer 10 (9%)
Histopathology Acute inflammation 10 (9%)
Chronic inflammation 19 (16%)
Acute on chronic inflammation 86 (75%)
Table 1. Demographic and clinical findings of patients (n=115).
an initial denaturation of target DNA at 94˚C for 5 min and
then denaturation at 94˚C for 1 min, primer annealing at
55˚C for 1 min and extension at 72˚C for 1 min. The final
cycle included an extension step for 7 min at 72˚C to ensure
full extension of the product. Samples were amplified
through 35 consecutive cycles.
The amplified products were resolved on 2% agarose gel
in 1x TAE buffer (40 mmol/L Tris-acetate, 1 mmol/L EDTA
[pH 8.0]) containing ethidium bromide (0.5 µg/mL) and then
visualised under ultraviolet (UV) light. 
vacA PCR analysis 
Amplification of vacA alleles by PCR was performed in a 25 µL
volume containing 10 mmol/L Tris-HCl (pH 8.3), 50 mmol/L
KCl, 1.5–2.5 mmol/L MgCl2, 200 µmol/L deoxynucleoside
triphosphates, 2 units Taq DNA polymerase (Promega) and
25 µmol forward and reverse primers (synthesised by an
MWG automatic synthesiser) (Table 2B).16
The amplification cycle for vacA alleles consisted of an
initial denaturation of target DNA at 95˚C for 5 min and
than denaturation at 95˚C for 1 min, primer annealing at
52˚C for 1 min and an extension at 72˚C for 1 min. The final
cycle included an extension step for 7 min at 72˚C to ensure
full extension of the product. Samples were amplified
through 35 consecutive cycles. 
Positive and negative reagent controls were performed
with each batch of amplifications. DNA from H. pylori strains
ATCC 43504 (vacAs1am1, cagA-positive), ATCC 51932 (vacA
s2m2, cagA-negative) and ATCC 43526 (vacAs1bm1, cagA-
positive) was used to define the accuracy of the vacA PCR. 
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Primer Primer sequence Amplicon (bp) Locationa
cagA-F1 5’-AACAGGACAAGTAGCTAGCC-3’ 349 2700–2719*
cagA-R1 5’-TATTAATGCGTGTGTGGCTG-3’ 3400–3381*
cagA-F2 5’-GATAACAGGCAAGCTTTTGA-3’ 701 157–176*
cagA-R2 5’-CTGCAAAAGATTGTTTGGCAGA-3’ 505–484*
cagE-F1 5’-GCGATTGTTATTGTGCTTGTAG-3’ 329 16,891–16,870†
cagE-R1 5’-GAAGTGGTTAAAAAATCAATGCCCC-3’ 16,563–16,587†
cagT-F1 5’-CCATGTTTATACGCCTGTGT-3’ 301 442–461†
cagT-R1 5’-CATCACCACACCCTTTTGAT-3’ 723–742†
LEC-F1 5’-ACATTTTGGCTAAATAAACGCTG-3’ 384 3920–3942‡
LEC-R1 5’-TCTCCATGTTGCCATTATGCT-3’ 4303–4283‡
LEC-F2 5’-ATAGCGTTTTGTGCATAGAA-3’ 877 3856–3875‡
LEC-R2 5’-ATCTTTAGTCTCTTTAGCTT-3’ 4732–4713‡
cagAP-F1 5’-GTGGGTAAAAATGTGAATCG-3’ 730 18,738–18,757†
cagAP-R1 5’-CTGCAAAAGATTGTTTGGCAGA-3’ 505–484*
cagAP-F2 5’-CTACTTGTCCCAACCATTTT-3’ 1181 18,495–18,514†
cagAP-R2 5’-CTGCAAAAGATTGTTTGGCAGA-3’ 505–484*
cagA empty site§ 360
2 5’-ACATTTTGGCTAAATAAACGCTG-3’
25 5’-TCATGCGAGCGGCGATGTG-3’
aGenBank Accession No: *AF001357; †U60176; ‡AC000108; §regions flanking the left and right ends of the 
cag-PAI insert location for NCTC 12455.
Table 2A. Sequences and locations of oligonucleotide primers.
Region amplified Primer Primer sequence Size and location of PCR product
m1 VA3-F 5’-GGTCAAAATGCGGTCATGG-3’ 290 bp (2741–3030)
VA3-R 5’-CCATTGGTACCTGTAGAAAC-3’
m2 VA4-F 5’-GGAGCCCCAGGAAACATTG-3’ 352 bp (976–1327)
VA4-R 5’-CATAACTAGCGCCTTGCAC-3’
S1a SS1-F 5’-GTCAGCATCACACCGCAAC-3’ 190 bp (866–1055)
VA1-R 5’-CTGCTTGAATGCGCCAAAC-3’
S1b SS3-F 5’-AGCGCCATACCGCAAGAG-3’ 187 bp (869–1055)
VA1-R 5’-CTGCTTGAATGCGCCAAAC-3’
a. Location in published cagA sequence (ref. 14).
b. Location in published vacA sequence (ref. 16).
Table 2B. Oligonucleotide primers used in typing of H. pylori vacA alleles.
Statistical assessment
The Statistical Package for Social Science SPSS (Release 11.5,
standard version, SPSS; 1989–99) was used for data analysis.
Descriptive analysis was performed for demographic and
clinical features. Results were presented as mean±SD for
quantitative variables and number (%) for qualitative
variables. Differences in proportion were assessed using
Pearson’s χ2 test, Fisher’s exact or likelihood ratio test, where
appropriate. P<0.05 was considered significant. 
Results
The clinical features and diagnosis of patients included in
the study are given in Table 1. Partial deletions involved 
cag I and cag II regions of the cag-PAI equally. In isolates from
NUD, deletions of cag-PAI genes were more frequent 
(Table 3A). These deletions predominantly involved cagE
and cagA promoter region of the cag-PAI (Table 3B). The
product corresponding to the cagA empty site was obtained
from five patients with partially intact cagA PAI, indicating
that they had mixed infections (i.e., a mixture of H. pylori
strains with and without the cagA gene).
Presence of cag-PAI genes
The cagA gene was positive in 66 (57%), cagA LEC in 63
(55%), cagAT in 63 (55%), cagAP region in 50 (43%) and cagAE
in 48 (42%) H. pylori isolates. In 31 (28%) isolates cag-PAI was
intact, it had partial deletions with some genes missing in 
42 (36%), and was completely deleted in 42 (36%). Deletions
were present in cagE (n=23 [37%], P<0.001) and in cagAP 
(23 [35%], P<0.001) (Figs. 1 and 2). 
Associations of cag-PAI genes with gastroduodenal disorders 
Association of H. pylori isolates with intact cag-PAI was seen
in GC (n=9[60%]), GU (n=5[45%]) and NUD (n=14[18%])
(Table 3A, Fig. 3). The cagA gene was associated with GU
(n=9[82%]) and GC (n=14[93%]), compared to NUD
(n=38[48%]) (P=0.049 and P=0.001, respectively). The cagAP
region was significantly associated with GC (n=14[93%],
P<0.001), GU (n=9[82%], P=0.001) and DU (n=7[70%],
P=0.016) compared to NUD (n=24[30%]). cagA LEC was
associated with GU (n=11[100%]) and GC (n=13[87%])
compared to NUD (n=40[51%]) (P<0.001 and P=0.010,
respectively). cagA LEC was also associated with GU
(n=11[100%]) compared to DU (n=5[50%]) (P=0.002) and
GC (n=13[87%]) compared to DU (n=5[50%]) (P=0.045).
cagE was associated with GU (n=7[64%], P=0.043) and GC
(n=13[87%], P<0.001) compared to NUD (n=25[32%]). cagT
was associated with GU (n=10[91%], P=0.006) and GC
(n=14[93%], P=0.002) compared to NUD (n=40[51%]).
Associations of cag-PAI genes with histology
In patients infected with H. pylori with intact cag-PAI, acute
on chronic inflammation was present in 25 (81%) (P=0.013,
Table 3A). In these patients, acute on chronic inflammation
was more common than chronic inflammation (P=0.014),
and cagAP (n=40 [47%], P=0.007) was associated with acute
on chronic inflammation. Intestinal metaplasia was present
in four (57%) isolates with intact cag-PAI (P=0.082). 
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cagPAI
Intact Partial Deleted
n(%) n(%) n(%)
31(28) 42(36) 42(36)
Diagnosis
Non-ulcer dyspepsia 14 (18) 28(35) 37(47)
Gastric ulcer 5(45) 6(55) 0
Gastric carcinoma 9 (60) 5(33) 1(7)
Duodenal ulcer 3 (30) 3(30) 4(40)
Histopathology
Inflammation
Acute inflammation 5(50) 3(30) 2(20)
Chronic inflammation 1(5) 12(63) 6(32)
Acute on chronic inflammation 25(29) 27(31) 34(39)
Lymphoid aggregates
Positive 26(31) 26(34) 30(35)
Negative 5(17) 13(43) 12(40)
Neutrophil infiltration
Mild 1(7) 7(50) 6(43)
Moderate 25(30) 27(33) 30(37)
Severe 5(26) 8(42) 6(32)
Table 3A. Correlation of cagPAI with diagnosis and histopathology.
Fig. 1. Distribution of cag-PAI gene amplified products in patients
with non-ulcer dyspepsia. Lane M: molecular weight marker 50 bp
(Promega); Lane A and B: cagA gene present; Lane C: cagA
promoter absent; Lane D: LEC present; Lane E: cagE absent; 
Lane F: cagT present.
M A B C D E F
850 bp
350 bp
300 bp
Fig. 2. Distribution of cag-PAI gene amplified products in patients with
duodenal ulcer. Lane M: molecular weight marker 50 bp (Promega);
Lane A and B: cagA gene present; Lane C: cagA promoter absent;
Lane D: LEC present; Lane E: cagE present; Lane F: cagT present.
M A B C D E F
850 bp
350 bp
300 bp
Fig. 3. Distribution of cag-PAI gene amplified products in patients 
with gastric carcinoma. Lane M: molecular weight marker 50 bp
(Promega); Lane A: cagA gene; Lane B: cagA promoter; Lane C: LEC;
Lane D: negative control; Lane E: cagE; Lane F: cagAT.
M A B C D E F M
850 bp
400 bp
350 bp
300 bp
Associations of cag-PAI genes with vacAs1a and m1
The presence of vacAs1a was seen in 80(70%) isolates and
that of vacAm1 was seen in 64(56%). Distribution of vacAs1a
with intact cag-PAI was GC (n=11[73%]), NUD (n=10[13%],
P<0.001), GU (n=4[36%], P=0.05) and DU (n=3[30%]
P=0.03). It was associated with acute inflammation in three
(30%) cases and acute on chronic inflammation in 20 (23%)
(P=0.164). Distribution of vacAm1 with intact cag-PAI was
GC (n=8[53%]), DU (n=3[30%]) and GU (n=3[27%])
compared to NUD (n=5[6%]) (P<0.001, P=0.038, P=0.050,
respectively). Acute on chronic inflammation was more
frequent (n=16[19%]) than chronic inflammation (P=0.008).
Discussion
The epidemiology of H. pylori infection remains important in
public health because of its high prevalence and its
association with gastric cancer and lymphoma. The
seroprevalence of H. pylori in the adult population of
Pakistan is reported as 58%.18 A recent study revealed early
colonisation/infection of infants with H. pylori and a
prevalence of 67% at nine months of age in a peri-urban
community in Karachi, Pakistan.19
In the present study, H. pylori isolates from patients with
NUD constituted the majority, which reflects the high
numbers in this group attending the gastroenterology clinic
and having endoscopy. H. pylori isolates with intact 
cag-PAI were associated with GC, GU and DU and 
on histopathology with acute and acute on chronic
inflammation. cagA gene, cagAP region, cagLEC, cagE and
cagT were all associated with GC, GU and DU compared to
NUD. 
H. pylori isolates from NUD lacked the cagAP region and
cagE (Fig. 1) while they were intact in those from GC (Fig. 2).
There was a significant difference in inflammatory
infiltration of the gastric mucosa between patients with
intact cag-PAI and those with partial cag-PAI type strains
(Table 3A). These findings suggest that the strains with
partial cag-PAI have less ability to cause inflammation than
those with intact cag-PAI. 
The implications of the present study are that cag-PAI is
partially intact in the majority of our clinical isolates. This is
consistent with a previous study in which cag-PAI appeared
cag pathogenicity island in H. pylori isolates 141
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Intact Partial Deleted
n(%) n(%) n(%)
31(28) 42(36) 42(36)
cagA Positive 31(46) 35(52) 0(0)
Negative 0(0) 7(14) 40(86)
cagAP Positive 31(62) 19(38) 0(0)
Negative 0(0) 23(35) 42(65)
cagLEC Positive 31(48) 32(49) 0(0)
Negative 0(0) 10(19) 42(81)
cagE Positive 31(65) 17(35) 0(0)
Negative 0(0) 23(37) 42(63)
cagT Positive 31(49) 32(51) 0(0)
Negative 0(0) 10(19) 42(81)
cagA empty site Positive 0(0) 5(11) 41(89)
Negative 31(45) 37(54) 1(1)
cagAP: cagA promoter region; LEC: left end of cag-PAI.
Table 3B. Distribution of cag-PAI genes in the clinical isolates.
cag-PAI s1a cag-PAI m1
Positive Negative P value Positive Negative P value
n(%) n(%) n(%) n(%)
Diagnosis
Non-ulcer dyspepsia 10(13) 69(87) 0.002 5(6) 74(94) <0.001
Gastric ulcer 3(27) 8(73) 3(27) 8(73)
Duodenal ulcer 2(20) 8(80) 3(30) 7(70)
Gastric carcinoma 9(60) 6(40) 8(53) 7(47)
Histopathology
Inflammation
Acute 3(30) 7(70) 0.164 3(30) 7(70) 0.016
Chronic 1(5) 18(95) 0(0) 19(100)
Acute on chronic 20(23) 66(77) 16(19) 70(81)
Lymphoid aggregates
Positive 20(23) 65(77) 0.237 3(10) 27(90) 0.243
Negative 4(13) 26(87) 16(19) 69(81)
Neutrophil infiltration
Mild 1(7) 13(93) 0.302 0(0) 14(100) 0.011
Moderate 18(22) 64(78) 18(22) 64(78)
Severe 5(26) 14(74) 1(5) 18(95)
cag-PAI: cag pathogenicity island.
Table 4. Relationship between intact cag-PAI and vacA subtypes in H. pylori strains.
to be partial in the majority of clinical isolates around the
world.19 Only 12% of the Indian isolates carried an intact 
cag-PAI. Deletion frequencies of cagA, cagE, and cagT genes
were higher in benign cases than in isolates from severe
ulcers and gastric cancer.19
In contrast, another study from Calcutta, India, showed
that 80–90% of Calcutta strains carried cag-PAI and the
potentially toxigenic vacAs1 alleles of vacA, independently of
disease status.20 In the present study, the clinical outcome of
H. pylori infection was predicted by analysing genes of the
cag-PAI, with the cagAP region and cagE more commonly
associated with GC and GU compared to NUD, which is
consistent with a previous study.21
Jenks et al. described the presence of cagE and correlated it
with that of cagA.22 However, in the present study it was
associated with the cagA promoter region. Also, the majority
of partial deletions of cag-PAI were observed in cagE,
followed by the cagAP region. 
The cagA gene promoter region appeared to be a better
marker of H. pylori virulence; however, it is known for the
diversity of its sequences in isolates. The cagE gene, which is
consistently retained near the cagAP region, appeared to be
a better substitute for the cagAP region. Also, cagE gene PCR
can be used to screen the cag-PAI structure, as suggested
previously.22
An association was noted between vacAs1a and vacAm1,
with intact cag-PAI. In the present study, vacAs1 with intact
cag-PAI was associated with GC, GU and DU. This is in
keeping with a previous study that showed vacAs1 occurs
significantly more often in isolates from patients with peptic
ulceration or gastric adenocarcinoma, while vacAs2
invariably occurs in patients with gastritis alone.23
A shortcoming of the present study is the small number of
patients in the different groups. The study, however, is
ongoing but the results presented here indicate that the
presence of the cagA gene does not signify the presence of an
intact cag-PAI, as most of the H. pylori isolates had partial 
cag-PAI with missing cagE and cagAP regions. 5
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